©The Author(s) 2017.
World J Gastrointest Pharmacol Ther. Feb 6, 2017; 8(1): 60-66
Published online Feb 6, 2017. doi: 10.4292/wjgpt.v8.i1.60
Published online Feb 6, 2017. doi: 10.4292/wjgpt.v8.i1.60
Table 1 Baseline demographics pancreatic adenocarcinoma (n = 97) n (%)
| Characteristic | Mean ± SEM |
| Age | 66 ± 0.9 |
| Weight at dx (lbs) | 80. 4 ± 1.7 |
| LMR | 2.36 ± 0.16 |
| CA 19-9 | 17030.2 ± 8861 |
| CEA | 960 ± 657 |
| Tumor size (cm) | 4.13 ± 0.2 |
| WBC | 9.1 ± 0.5 |
| Platelets | 276.8 ± 12.2 |
| ALC K/μL | 1.5 ± 0.07 |
| AMC K/μL | 0.74 ± 0.03 |
| Race | |
| White | 64 (66) |
| Black | 29 (30) |
| Other | 4 (4) |
| Location | |
| Head | 64 (71) |
| Body | 10 (11) |
| Tail | 16 (18) |
| Stage | |
| I | 1 (1) |
| II | 23 (24) |
| III | 14 (14) |
| IV | 59 (61) |
| Treatment | |
| Surgery | 22 (23) |
| Stent | 38 (39) |
| Any chemo/rad | 44 (45) |
| Palliative chemotherapy | 36 (37) |
| Neoadjuvant chemotherapy | 3 (3) |
| Adjuvant chemotherapy | 10 (10) |
| Risk factors | |
| Alcohol | 53 (55) |
| Tobacco | 76 (78) |
- Citation: Singh G, Nassri A, Kim D, Zhu H, Ramzan Z. Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma. World J Gastrointest Pharmacol Ther 2017; 8(1): 60-66
- URL: https://www.wjgnet.com/2150-5349/full/v8/i1/60.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v8.i1.60